Concepedia

Publication | Open Access

Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma

92

Citations

41

References

2022

Year

Abstract

This study finds that cholesterol biosynthesis supports the expansion of cancer stem cell populations to drive resistance to tyrosine kinase inhibitor therapy in hepatocellular carcinoma, identifying potential therapeutic approaches for improving cancer treatment.

References

YearCitations

2008

5.8K

2018

5.3K

2007

1.2K

2008

1.2K

2010

702

2011

587

2018

442

2007

432

2016

372

1996

315

Page 1